Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

BACKGROUND: Pentraxin 3 is proposed to be a marker of inflammation and cardiovascular risk, but its role in inflammatory rheumatic diseases (IRDs) is still uncertain. Therefore, we wanted to examine if anti-rheumatic treatment reduced serum PTX3 (s-PTX3) levels in IRDs, and if s-PTX3 levels were rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Deyab, Gia, Hokstad, Ingrid, Whist, Jon Elling, Småstuen, Milada Cvancarova, Agewall, Stefan, Lyberg, Torstein, Bottazzi, Barbara, Meroni, Pier Luigi, Leone, Roberto, Hjeltnes, Gunnbjorg, Hollan, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321277/
https://www.ncbi.nlm.nih.gov/pubmed/28225768
http://dx.doi.org/10.1371/journal.pone.0169830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321277/
https://www.ncbi.nlm.nih.gov/pubmed/28225768
http://dx.doi.org/10.1371/journal.pone.0169830

Ejemplares similares